Abstract:Objective: Cancer is a complex genetic disease characterized by the accumulation of various mutations, with driver genes playing a crucial role in cancer initiation and progression. Distinguishing driver genes from passenger mutations is essential for understanding cancer biology and discovering therapeutic targets. However, the majority of existing methods ignore the mutational heterogeneity and commonalities among patients, which hinders the identification of driver genes more effectively. Methods: This study introduces MCSdriver, a novel computational model that integrates network and pathway information to prioritize the identification of cancer driver genes. MCSdriver employs a bidirectional random walk algorithm to quantify the mutual exclusivity and functional relationships between mutated genes within patient cohorts. It calculates similarity scores based on a mutual exclusivity-weighted network and pathway coverage patterns, accounting for patient-specific heterogeneity and molecular profile similarity. Results: This approach enhances the accuracy and quality of driver gene identification. MCSdriver demonstrates superior performance in identifying cancer driver genes across four cancer types from The Cancer Genome Atlas, showing a higher F-score, Recall and Precision compared to existing ranking list-based and module-based models. Conclusion: The MCSdriver model not only outperforms other models in identifying known cancer driver genes but also effectively identifies novel driver genes involved in cancer-related biological processes. The model's consideration of patient-specific heterogeneity and similarity in molecular profiles significantly enhances the accuracy and quality of driver gene identification. Validation through Gene Ontology enrichment analysis and literature mining further underscores its potential application value in personalized cancer therapy, offering a promising tool for advancing our understanding and treatment of cancer.

AI-Driver: an Ensemble Method for Identifying Driver Mutations in Personal Cancer Genomes.

DriverML: a Machine Learning Algorithm for Identifying Driver Genes in Cancer Sequencing Studies

DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.

DriverMP enables improved identification of cancer driver genes

deepDriver: Predicting Cancer Driver Genes Based on Somatic Mutations Using Deep Convolutional Neural Networks.

Enhancing Cancer Driver Gene Prediction by Protein-Protein Interaction Network

Identifying Driver Genes for Individual Patients Through Inductive Matrix Completion

A Novel Unsupervised Learning Model For Detecting Driver Genes From Pan-Cancer Data Through Matrix Tri-Factorization Framework With Pairwise Similarities Constraints

Machine learning optimized DriverDetect software for high precision prediction of deleterious mutations in human cancers

Discovering potential driver genes through an integrated model of somatic mutation profiles and gene functional information.

AlloDriver: a Method for the Identification and Analysis of Cancer Driver Targets

CDMPred: a tool for predicting cancer driver missense mutations with high-quality passenger mutations

DriverFinder: A Gene Length-Based Network Method to Identify Cancer Driver Genes

Advancing cancer driver gene identification through an integrative network and pathway approach

Combined burden and functional impact tests for cancer driver discovery using DriverPower

DRIVE: Machine Learning to Identify Drivers of Cancer with High-Dimensional Genomic Data & Imputed Labels

Identifying Driver Mutations from Sequencing Data of Heterogeneous Tumors in the Era of Personalized Genome Sequencing

Personalized Driver Gene Prediction Using Graph Convolutional Networks with Conditional Random Fields

A novel missense-mutation-related feature extraction scheme for 'driver' mutation identification.

C3: Consensus Cancer Driver Gene Caller.

pDriver : a novel method for unravelling personalized coding and miRNA cancer drivers